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Abstract
Background: HIP1 Protein Interactor (HIPPI) is a pro-apoptotic protein that induces Caspase8 mediated apoptosis
in cell. We have shown earlier that HIPPI could interact with a specific 9 bp sequence motif, defined as the HIPPI
binding site (HBS), present in the upstream promoter of Caspase1 gene and regulate its expression. We also have
shown that HIPPI, without any known nuclear localization signal, could be transported to the nucleus by HIP1, a
NLS containing nucleo-cytoplasmic shuttling protein. Thus our present work aims at the investigation of the role of
HIPPI as a global transcription regulator.
Results: We carried out genome wide search for the presence of HBS in the upstream sequences of genes. Our
result suggests that HBS was predominantly located within 2 Kb upstream from transcription start site.
Transcription factors like CREBP1, TBP, OCT1, EVI1 and P53 half site were significantly enriched in the 100 bp vicinity
of HBS indicating that they might co-operate with HIPPI for transcription regulation. To illustrate the role of HIPPI
on transcriptome, we performed gene expression profiling by microarray. Exogenous expression of HIPPI in HeLa
cells resulted in up-regulation of 580 genes (p < 0.05) while 457 genes were down-regulated. Several transcription
factors including CBP, REST, C/EBP beta were altered by HIPPI in this study. HIPPI also interacted with P53 in the
protein level. This interaction occurred exclusively in the nuclear compartment and was absent in cells where HIP1
was knocked down. HIPPI-P53 interaction was necessary for HIPPI mediated up-regulation of Caspase1 gene. Finally,
we analyzed published microarray data obtained with post mortem brains of Huntington’s disease (HD) patients to
investigate the possible involvement of HIPPI in HD pathogenesis. We observed that along with the transcription
factors like CREB, P300, SREBP1, Sp1 etc. which are already known to be involved in HD, HIPPI binding site was also
significantly over-represented in the upstream sequences of genes altered in HD.
Conclusions: Taken together, the results suggest that HIPPI could act as an important transcription regulator in cell
regulating a vast array of genes, particularly transcription factors and at least, in part, play a role in transcription
deregulation observed in HD.
Background
HIPPI (HIP1 Protein Interactor) was identified by Ger-
vais and co-workers as an interacting partner of Hun-
tingtin Interacting Protein 1 (HIP1). HIPPI interacts
with HIP1 through its pseudo death effector domain
(pDED) and the resulting heterodimer recruits Procas-
pase8 and activates it thereby inducing Caspase8-
mediated apoptosis [1]. Subsequently we have shown in
detail the downstream pathways of Caspase8 activation
leading to cell death in neuronal and non-neuronal cells
[2]. Such non-receptor mediated induction of apoptosis
may play a role in Huntington’s disease (HD) pathogen-
esis. HD is an autosomal dominant neurodegenerative
disease caused by the expansion of poly glutamine (Q)
stretch at the N-terminus of the protein Huntingtin
(HTT) [3]. HIP1 interacts strongly with wild type HTT
but the interaction is feeble with mutant HTT [4]. Thus,
in the diseased condition where one of the HTT allele is
mutated, the freely available HIP1 in the cytoplasm may
undergo heterodimerization with HIPPI, which in turn
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any medium, provided the original work is properly cited.activate Caspase8 [1]. In addition, exogenous expression
of HIPPI also increases the expression of Caspase1, Cas-
pase3, Caspase7 and Caspase8 in cells as well as it
induces truncation of Bid and release of AIF from mito-
chondria [2]. Although the protein lacks any conven-
tional DNA binding domain, it is shown to interact in
vitro and in vivo with a specific 9 bp DNA sequence 5’-
AAAGACATG-3’ present at the putative promoter of
Caspase1 gene and positively regulate its transcription.
Using various variants of the motif, we observed that
HIPPI binds with the motif (AAAGA[G/C]A[A/C/T][T/
G]) [5-7].
Structural analysis of HIPPI failed to detect any
known protein domain except for a pseudo death effec-
tor domain (pDED) and a myosin like domain (MLD).
The protein does not contain nuclear localization signal
(NLS) and therefore is expected to translocate to
nucleus via some carrier protein. Earlier study from our
lab demonstrates that HIP1 acts as the carrier for
HIPPI. The HIPPI-HIP1 heterodimeric protein complex
formed in cytoplasm enters the nucleus through the
NLS present at the C terminus of HIP1 [8] and assem-
bles on the putative promoter of Caspase1 gene to regu-
late its transcription [9].
The role of HIPPI as a transcription regulator of Cas-
pase1 thus imparts a new function to the protein. It is,
therefore, important to identify other genes that could
be regulated by HIPPI and the downstream effect of
such regulation in cells. Gene expression regulation is a
complex phenomenon in which several transcription
factors work in concert to bring about the alteration.
Thus, it is also important to look for the involvement of
other cellular transcription factors in HIPPI mediated
transcription regulation. In an attempt to decipher HIP-
PI’s role as a general transcription regulator, in the pre-
sent communication, we carried out genome wide
search for the presence of HIPPI binding sites in the
upstream sequences of genes coded by the human gen-
ome. Using our in-house search tool, we also predicted
other transcription factors that might co-operate with
HIPPI. Finally, to study the global changes in gene
expression by HIPPI in cell, microarray experiment was
carried out. One of our aims was to investigate the role
of HIPPI in Huntington’s disease pathogenesis. For this,
we analyzed the gene expression data obtained by
Hodges et al., [10]. Subsequent analysis of all the data
could establish HIPPI’s role as a global transcription
regulator as well as its involvement in the deregulation
of genes in HD.
Methods
Development of search tools
In our study, the computational analysis of transcription
factor binding site (TFBS) enrichment was performed
using an in house custom made tool. A set of 245 posi-
tion weight matrices (PWMs), corresponding to known
vertebrate TFBSs were obtained from the publicly avail-
able TRANSFAC database [11]. Binding sites of two
other TFs, HIPPI [6] and NRSF/REST [12,13] were also
included in this list. 10 Kb upstream sequences (5’ of
TSS) of all Human (version GrCh37) and Mouse (ver-
sion NCBIM37) protein-coding genes were retrieved
using the Biomart utility provided by Ensembl web ser-
ver (http://www.ensembl.org/biomart/martview). The
Human-mouse homolog genes were also determined
using the same Biomart utility of the Ensembl web
server.
PWM search (including both strands) with various
similarity cutoff levels were performed to identify the
location of each putative TFBS in all human and mouse
10 Kb upstream sequences. Enrichment of TFBS was
analyzed among a target and a background set of
upstream sequences using two different statistical tests.
Depending on the source organism of the target genes
(human or mouse) the entire collection of non-redun-
dant human/mouse upstream sequences was used as the
background set. The binding sites for which the cumula-
tive hypergeometric P-value or the Chi square test P-
values was less than 0.05 were considered to be enriched
in the target upstream sequence set.
Transcription factor binding site analysis
To identify the genes that harbor the 9 bp HIPPI bind-
ing motif (AAAGA[G/C]A[A/C/T][T/G]) in their
upstream promoter region, we searched the 10 Kb
upstream sequences of all the genes in the human gen-
o m eu s i n gt h ei n - h o u s em a t r i xs e a r c ht o o l( M S T ) .T h e
Matrix combination search tool (MCST) was used to
identify co-occurrence of HIPPI binding sites and other
transcription factor binding sites in the gene promoters
within a defined distance (100 bp). Functional classifica-
tion of selected genes was performed by data retrieval
tool. Functional classes having hypergeometric p value
(corrected using Benjamini and Hochberg method) less
than 0.05 were selected.
Additionally, TF binding site analysis and GO analysis
on subset of genes were carried out using online tool
Genecodis v2.0 [14,15].
Dataset preparation for Huntington’s disease microarray
analysis
Microarray data obtained from HD patients’ brain sam-
ple [10] were analyzed to study the involvement of
HIPPI in HD pathogenesis. In the original study, Hodges
et al., analyzed the mRNA expression level in 44 HD
patients (Vonsattel Grades 0-4) and 36 age and sex
matched controls using Affimetrix HG-U133A and HG-
U133B arrays. Expression profiling was done for
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cortex) and BA9 (prefrontal association cortex). A statis-
tical criterion p < 0.001 was used to obtain the differen-
tially expressed genes. For our analysis, we downloaded
the gene expression data for caudate, the brain region
mostly affected in HD and sorted them based on the
statistical significance (p < 0.05). We used false discov-
ery rate (FDR, Benjamini and Hochberg method) for
multiple testing of the array data and genes having cor-
rected p value less than 0.05 were selected for analysis.
The gene ids of the differentially regulated genes were
converted to their corresponding Ensembl ids using
Ensembl Biomart and analyzed using the in house
search tools as described above.
Antibodies and other reagents
Geniticin, Hygromycin, and anti Beta-actin (A2228, clone
AC-74, Lot number: 107K4791) antibody were obtained
from Sigma Chemicals (MO, USA). The anti-mouse and
anti-rabbit secondary antibodies conjugated with horse-
radish peroxidase and protein A agarose beads were pur-
chased from Bangalore Genei, India. Anti HIPPI antibody
(ab5205-100, Lot number: 63362) was purchased from
Abcam, USA. Anti P53 (IMG 80061) and anti Caspase1
antibodies (IMG-804-4, Lot number: AB093004A) were
purchased from Imgenex, USA. Anti HIP1 antibody
(NB300-204, 1B11, Lot number: A) was purchased from
Novus Biologicals. Immobilon-P Transfer membrane was
from Millipore, USA, Taq polymerase from Bioline, USA,
and restriction enzymes (BamHI, SalI, and HindIII) were
from Promega, USA. Protease inhibitor cocktail was pur-
chased from Roche, USA. TRIZOL reagent was obtained
from Invitrogen, USA. Microarray labeling kit was from
GE Healthcare. Other molecular biology grade fine che-
micals were procured locally.
Construction of clone
Construction of GFP-Hippi has been described earlier
[2]. In brief, full length human HIPPI was cloned in
pEGFPC1 vector between SalI and BamHI sites. Full
length p53 cloned in pCMV neo bam vector was kindly
gifted by Dr. Susanta Roychoudhury, Indian Institute of
Chemical Biology, Kolkata.
Cell culture and transfection
HeLa and Neuro2A cells were routinely grown in MEM
(HIMEDIA, India) supplemented with 10% fetal bovine
s e r u m( B i o w e s t ,U S A . )a t3 7 ° Ci n5 %C O 2 atmosphere
under humidified condition. Transfection of cells was
performed using Lipofectamine 2000 (Invitrogen, USA).
Unless otherwise mentioned, for single transfection
experiment 2.5 μg (60 mm plate) or 5 μg( 1 0 0m m
plate) of DNA constructs as well as 5 μlo r1 0μlo f
Lipofectamine 2000 respectively were used. After 24 h,
transiently transfected cells were checked for transfec-
tion efficiency by monitoring GFP expression under
fluorescence microscope and were used for experiments.
Transfection efficiency varied from 70-90%.
Knockdown of HIP1 and p53 in HeLa cells
K n o c kd o w no fHIP1 in HeLa cells by sequence specific
siRNA has been described earlier [9]. Briefly, DNA
sequences 779-ACCGCTTCATGGAGCAGTTTA-799
of human HIP1 (gi|38045918|ref|NM_005338.4|) were
used for designing the siRNA using the online software
from GenScript (https://www.genscript.com/ssl-bin/app/
rnai). The complete sequence inserted into the expres-
sion vector pRNATin-H1.2/Hygro was 5’-TAAA
CTGCTCCATGAAGCGGTTTGATATCCGACCGCTT-
CATGGAGCAGTTTATTTTTTCCAA-3’ (designated
Hip1Si) with termination signal and appropriate restric-
tion site linkers (BamH1 and HindIII, not shown) and
an insert for loop formation (underlined). The clones
were checked by restriction digestion. HIP1 siRNA
clone was transfected in HeLa cells using Lipofectamine
2000 (Invitrogen, USA) following manufacturer’sp r o t o -
col. Stably transfected cells were selected by Hygromy-
cin resistance. Knock down of HIP1 in these cells was
confirmed by western blot analysis using anti HIP1
antibody.
For knock down of HIP1 in Neuro 2A cells, the same
siRNA construct and protocol was used as described
above.
For generating p53 knock down HeLa cell line, pSup-
pressorNeo p53 plasmid DNA containing p53 siRNA
construct (Imgenex, USA, catalog no. IMG 803) was
used.
Microarray study
For microarray study, total RNA from cell was extracted
using RNeasy Mini Kit (Qiagen, USA) following manufac-
turer’s protocol. RNA samples were quantified by measur-
ing the absorbance at 260 nm and purity was determined
using the OD
260/OD
280 ratio. For cDNA preparation and
labeling of the cDNA with fluorescent dyes Cy3 and Cy5,
10 μg of total RNA was reverse transcribed and labeled
using CyScribe Post-Labeling Kit (GE Healthcare). Equal
concentration of differentially labeled control and test
samples were mixed and hybridized to the whole genome
human 40 K array (Ocimum Biosolutions, India). Hybridi-
zation was carried out over night at 42°C in Hybstation
(Genomic Solution). Hybridized array was scanned using
GenePix Pro 4200 A scanner. Each experiment was
repeated four times, twice with swapping the dye.
Analysis of Microarray data
Analysis of microarray data was carried out by GenePix
Pro 6.0 soft ware. The GenePix Result file (GPR)
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4.0 soft ware for statistical analysis. Significantly altered
probes were identified by student’stt e s t( p<0 . 0 5 ) .
Using the same software, the correction for multiple
testing was carried out. The detail protocol and array
data has been submitted to Gene Expression Omnibus
database (http://www.ncbi.nlm.nih.gov/geo) GEO acces-
sion nos. GSE26115 and GSE26116).
Semi quantitative RT-PCR
Total RNA was extracted from cells using TRIZOL
reagent (Invitrogen, USA). Two μg RNA was reverse
transcribed using random hexamer primer (Fermentas,
USA) and MuLv-Reverse transcriptase (Fermentas,
USA). Semi quantitative RT-PCR was carried out using
Red Taq DNA polymerase (Bioline, USA). Expression of
beta actin was taken as endogenous control. Densitome-
try of the bands was done using Image Master VDS
software (Amarsham Biosciences, UK). The primer
sequences used for the gene expression analysis are
listed below.
CBP-F: 5’ TTGCAGAGGTCTTTGAGCAGG 3’
CBP-R: 5’ ATCGCGAGGAATGGTACACAG 3’
GNG10-F: 5’ TGGTAGAGCAGCTCAAGTTGG 3’
GNG10-R: 5’ TCAGAGTAAAGCACAGGATCTAGG
3’
CREB3L2-F: 5’ CCCTTCACCCACATTACCAC 3’
CREB3L2-R: 5’ TCATTTCCAGAGGAGGTTCC 3’
CACNG1-F: 5’ TGTCCCTCGGGAAGAAGAG 3’
CACNG1-R: 5’ CAGGCAAAGGACCAGGAGTA 3’
VTI1A-F: 5’ GCAAATTGGTCAGGAGATGTT 3’
VTI1A-R: 5’ GATGGTGATGACCACGATGA 3’
NKX2-5-F: 5’ ACCCAGCCAAGGACCCTA 3’
NKX2-5-R: 5’ GCGTGGACGTGAGTTTCAG 3’
C/EBPb-F: 5’ GAGCAAGGCCAAGAAGACC 3’
C/EBPb-R: 5’ AGCTGCTCCACCTTCTTCTG 3’
ID1-F: 5’ GCTCTACGACATGAACGGCTGT 3’
ID1-R: 5’ GTTCCAACTTCGGATTCCGAGT 3’
CCL5-F: 5’ CTGCTGCTTTGCCTACATTGC 3’
CCL5-R: 5’ CCGAACCCATTTCTTCTCTGG 3’
ITPR1-F: 5’ ACCTGCTGGTGGCGTTTTT 3’
ITPR1-R: 5’ TGAGAGGCAGGAAGAGCAGAGA 3’
Sub-cellular fractionation, Immunoprecipitation and
Western Blot analysis
Methods for sub-cellular fractionation, immunoprecipi-
tation and Western blot analysis were essentially the
same as described earlier [9]. Briefly, cells grown in 100
mm Petri dishes were washed with ice cold PBS and
harvested at 300 g for 3 min at 4°C. Cytosol was
extracted using cytosol extraction buffer (50 mM Tris-
Cl pH 7.5, 10 mM NaCl, 2 mM EDTA, 1 mM PMSF
and 1X protease inhibitor cocktail, 0.25% NP-40). The
nuclear pellet was then suspended in nuclear IP buffer
(50 mM Tris-Cl pH 7.5, 150 mM NaCl, 2 mM EDTA, 1
mM PMSF and 1X protease inhibitor cocktail) followed
by repeated freezing and thawing and centrifugation at
13,000 g for 20 min at 4°C. The extracts were then incu-
bated with anti P53 antibody (1:100 dilution) and BSA
soaked protein-A agarose beads and kept overnight at 4°
C under continuous rotating condition. Next day the
immunoprecipitated complex was collected by centrifu-
gation at 1000 g for 2 min at 4°C. Beads were washed
a n db o i l e dw i t hS D Sg e ll o a d i n gb u f f e ra n dw e r es u b -
jected to western blot using anti HIPPI and anti P53
antibodies.
For immunoprecipitation assay using whole cell
extract, cell lysis was carried out using co-immunopreci-
pitation buffer (50 mM Tris-Cl pH 7.5, 15 mM EDTA,
100 mM NaCl, 0.1% Triton X-100 and PMSF with 100
μg/ml final concentrations). Beta actin was used as
internal loading control. Integrated optical density
(IOD) of each band was calculated using Image Master
VDS software (Amarsham Biosciences, UK). Whenever
necessary, IOD was normalized with that of the loading
control.
Statistical analysis
All the experiments (except microarray experiment)
were done for three times. Statistical analysis, mainly
unpaired t test was carried out using the on-line soft-
ware GraphPad QuickCalc available at http://www.
graphpad.com/quickcalcs/ttest1.cfm
Result
Genome wide search for the presence of HIPPI binding
sites in the upstream of coding genes
To identify genes that could be regulated by HIPPI, we
carried out a genome wide search for the presence of 9
bp HIPPI binding motif (AAAGA[G/C]A[A/C/T][T/G])
as described earlier [6] in the upstream sequences of
genes coded by the human genome. Initially, we started
with 10 Kb upstream sequences and then narrowed it
down to 1 Kb upstream. Using a score 1.0 (perfect
match) MST (please see the materials and methods)
predicted that 1872 (7.9%) out of total 23,607 genes
contained HIPPI binding site (HBS) within 1 Kb
upstream of their coding strands. This number increased
to 14,586 (61.8%) when we searched 10 Kb upstream
sequences. The distribution of HBS along the 10 Kb
upstream of genes starting from the transcription start
site (TSS, taken as position ‘0’) in the window of 1 Kb is
graphically represented in Figure 1. Result showed that
majority of the genes contained the binding site within
2 Kb upstream and frequency decreased at a longer dis-
tance from TSS. As HIPPI is a non-conventional tran-
scription regulator, we therefore compared this
distribution pattern with another known transcription
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were mainly concentrated within 1 Kb upstream of
genes and showed similar pattern to that of HIPPI. As
HBS was mainly enriched within 2 Kb upstream from
TSS, we took those genes bearing HBS within their 2
Kb upstream promoters (3988, Additional file 1) and
subsequently analyzed them by Gene Ontology (GO) for
functional classification. The genes showed involvement
in diverse cellular functions. Molecular functions like
receptor activity (GO:0004872), sequence-specific DNA
binding (GO:0043565), transcription factor activity
(GO:0003700), transcription regulator activity
(GO:0030528), chromatin binding (GO:0003682) and
biological processes like signal transduction
(GO:0007165), regulation of transcription, DNA-depen-
dent (GO:0006355), translation (GO:0006412), synaptic
transmission (GO: 0007268), positive regulation of tran-
scription from RNA polymerase II promoter
(GO:0045944), DNA damage response, signal transduc-
tion resulting in induction of apoptosis (GO:0008630),
etc. were significantly enri c h e dc a t e g o r y( T a b l e1a n d
Additional file 2).
Enrichment of other transcription factor binding sites in
the vicinity of HIPPI binding site
Generally transcription factors act in combinatorial
manner to regulate target gene expression [16] and it is
expected that binding sites for those transcription fac-
tors that work in concert should co-occur within a close
distance. Thus, to identify the transcription factor part-
ners in HIPPI mediated transcriptional regulation, we
searched for the co-occurrences of other transcription
factor binding sites within 100 bp distance on either
side of HBS in the upstream sequence of the genes (Fig-
ure 2a). Since HBS was mainly centered within 2 Kb
upstream regions, we confined our search with those
genes containing HBS within 2 Kb upstream. Using a
cut off score 0.9 for the second transcription factor, 14
TFs were found to be significantly overrepresented (p <
0.05) within 100 bp on either side of HBS (Figure 2b).
These TFs include Nuclear factor of activated T cells
(NFAT), CCAAT enhancer binding protein beta (C/EBP
beta), Tumor protein 53 (P53), pre-B-cell leukemia
homeobox 1 (PBX1), GATA binding protein 1
(GATA1), TATA box binding protein (TBP), POU class
2h o m e o b o x1( O C T 1 ) ,F o r k h e a db o xJ 2( F O X J 2 ) ,
nuclear factor, interleukin 3 regulated (E4BP4), runt-
related transcription factor 1 (RUNX1/EVI1), cAMP
response element binding protein 1 (CREBP1), Forkhead
box C1 (FOXC1/FREAC3), HNF1 homeobox A (HNF1)
and Hepatocyte nuclear factor 4, alpha (HNF4). These
TFs, therefore, may have role in HIPPI mediated tran-
scription regulation.
Alteration of gene expression by HIPPI: microarray study
To explore the effect of HIPPI on cellular transcriptome,
we carried out gene expression profiling by microarray.
HeLa cells exogenously transfected with GFP-Hippi con-
struct (designated as ‘HeLa-Hippi’)w a st a k e na st e s t
sample while HeLa cells transfected with empty GFP
vector (designated as ‘HeLa-Gfp’)s e r v e da sc o n t r o la n d
relative level of transcripts were compared between
these cells by microarray. Among 39,936 spots in the
array we observed up-regulation of 580 genes (p < 0.05)
while 457 genes were down regulated (p < 0.05, Table 2,
Additional file 3). These set of genes were then analyzed
for the presence of transcription factor binding sites in
their upstream. In contrary to our expectation, HBS was
not significantly enriched in the upstream of either up
or down-regulated genes. But several other transcription
factors including specificity protein 1 (Sp1), Activator
protein 2 (AP2), C-Rel, NF-kappaB p65 (relA), E47 etc
were significantly (p < 0.05) enriched within 10 Kb
upstream of the up-regulated genes (Figure 3a) while
the down-regulated genes harbored binding sites for
OCT1, NFAT, EVI1, HSF2 etc (Figure 3b). Binding sites
for CREB was enriched in both up and down-regulated
genes. TF binding site analysis was also carried out
using a second method. The online tool Genecodis v2.0
[14,15] was used for this purpose. Along with the TFs
obtained from our tool, Genecodis predicted the enrich-
ment of P53 in the upstream of up-regulated genes
(Additional file 4). Functional classification of these
Figure 1 Distribution of HIPPI binding site (HBS) along the 10
Kb upstream sequences of all the genes in the human
genome. Distance was calculated taking the transcription start site
(TSS) as ‘0’. Frequency of occurrence of HBS per kb distance was
plotted against the distance from TSS. CREB binding site distribution
(Red line) along the same distance was shown to compare the
pattern of distribution.
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molecular functions and biological processes (Table 3
and Additional file 5). Transcription factor activity
(GO:0003700), chromatin binding (GO:0003682), tran-
scription co-activator activity (GO:0003713), transcrip-
tion repressor activity (GO:0016564), sequence-specific
DNA binding (GO:0043565) were some of the
significantly enriched molecular function and positive
regulation of transcription, DNA-dependent
(GO:0045893), negative regulation of transcription from
RNA polymerase II promoter (GO:0000122), translation
(GO:0006412) were some of the significantly enriched
biological processes for the up-regulated genes while
down-regulated genes were enriched in the molecular
Table 1 GO Molecular Function and Biological Process analysis of the genes having HBS within 2 Kb upstream
sequence
Molecular functions
GO ID GO details Data set
frequency
(%)
Background
frequency
(%)
p value
(unadjusted)
p value
(corrected)
Gene name
GO:0004872 Receptor activity 9.84549 5.767347 5.71E-20 1.10E-17 Transforming growth factor, beta receptor 1,
glutamate receptor, ionotropic, N-methyl D-
aspartate 2D, gamma-aminobutyric acid (GABA) B
receptor, 2
GO:0043565 Sequence-specific DNA
binding
4.132231 2.602547 2.88E-07 9.29E-06 cAMP responsive element binding protein 1,
Activating transcription factor 2, CCAAT/enhancer
binding protein (C/EBP), gamma, POU class 4
homeobox 2
GO:0003700 Transcription factor
activity
6.324111 4.527836 2.17E-06 6.00E-05 CREB/ATF bZIP transcription factor, cAMP
responsive element binding protein 1, activating
transcription factor 2, Signal transducer and
activator of transcription 4, Transcription factor
AP-2 beta
GO:0030528 Transcription regulator
activity
3.162055 1.967883 4.25E-06 0.00010965 Inhibitor of DNA binding 1, dominant negative
helix-loop-helix protein, POU class 4 homeobox
2, HMG-box transcription factor 1
GO:0003682 Chromatin binding 1.401365 0.758189 0.0001005 0.001620659 CREB binding protein, RE1-silencing transcription
factor, polymerase (DNA directed), alpha 1,
catalytic subunit, SWI/SNF related, matrix
associated, actin dependent regulator of
chromatin, subfamily e, member 1
Biological process
GO:0007165 Signal transduction 14.94077 8.710653 6.47E-29 3.07E-26 Protein kinase, cAMP-dependent, regulatory, type
II, beta, CREB binding protein, cAMP responsive
element modulator, Transforming growth factor,
beta receptor 1, cAMP responsive element
binding protein 1, Caspase 1, apoptosis-related
cysteine peptidase
GO:0006355 Regulation of
transcription, DNA-
dependent
9.70577 5.865315 1.04E-16 9.88E-15 CREB binding protein, Nuclear transcription factor
Y, alpha, Nuclear factor of activated T-cells,
cytoplasmic, calcineurin-dependent 4, cAMP
responsive element binding protein 1, Cyclin-
dependent kinase inhibitor 2A
GO:0006412 Translation 3.018724 1.682498 1.67E-07 7.21E-06 Eukaryotic translation initiation factor 6, WD
repeat-containing protein 46
GO:0007268 Synaptic transmission 1.337409 0.694297 0.000101 0.001916701 Synapsin I, Neurexin 2, Amyloid beta (A4)
precursor protein-binding, family A, member 1,
Glutamate decarboxylase 1 (brain, 67 kDa),
Gamma-aminobutyric acid (GABA) B receptor, 2
GO:0045944 Positive regulation of
transcription from RNA
polymerase II promoter
2.216278 1.478042 0.001084 0.01355529 Nuclear transcription factor Y, alpha,
Transforming growth factor, beta 3, CREB binding
protein, SMAD family member 4, Thyroid
hormone receptor, beta,
GO:0008630 DNA damage response,
signal transduction
resulting in induction of
apoptosis
0.22927 0.068152 0.005672 0.04954832 Methyl-CpG binding domain protein 4. Ataxia
telangiectasia mutated. CHK2 checkpoint
homolog (S. pombe)
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(GO:0004888), transcription repressor activity
(GO:0016564), transcription co-repressor activity
(GO:0003714) and biological processes like synaptic
transmission (GO:0007268), signal transduction
(GO:0007165), negative regulation of transcription from
RNA polymerase II promoter (GO:0000122) etc. It is
worthy of mentioning that some of these molecular
functions like transcription factor activity, chromatin
binding, sequence-specific DNA binding and biological
processes like signal transduction, regulation of tran-
scription, DNA-dependent, synaptic transmission were
already predicted when we performed genome wide ana-
lysis of HBS containing genes (Table 1 and Additional
file 2). The genes possessing HIPPI binding sites among
the deregulated genes were analyzed separately for their
involvement in cellular functions. We found that among
the up-regulated genes, 342 genes contained HBS within
10 Kb upstream sequence and they were enriched in
molecular functions like RNA polymerase II transcrip-
tion factor activity (GO:0003702), transcription factor
activity, (GO:0003700) and biological processes like reg-
ulation of transcription (GO:0045449) (Additional file
6). In case of the down-regulated genes, HBS was pre-
sent within 10 Kb upstream sequence for 259 genes and
they were enriched in biological processes like signal
transduction (GO:0007165), synaptic transmission, glu-
tamatergic (GO:0035249) etc. (Additional file 6). Again,
some of these GO terms and some related GO terms
were already found to be enriched when we performed
Figure 2 Co-occurrence of HBS and other transcription factor binding sites in the genome. A. Schematic representation of the region
searched for the co-occurrence of HBS and other transcription factor binding sites. Hundred (100) base pair region on either side of HBS (grey
shaded) were taken into consideration. B. Transcription factors whose binding sites were significantly enriched (p < 0.05) in the 100 bp region
on either side of HBS in the 2 Kb upstream of genes. Data set represents the set of genes in the human genome having HBS within 2 Kb
upstream regions. The occurrence of a particular motif within 100 bp distance of HBS in the data set was divided by the occurrence of that
motif in the background and the ratio was plotted against the TF. The p value in the figure represents the significance level of enrichment for
the transcription factor.
Table 2 Altered genes in Microarray Study
Experiment No. of probes altered No. of probes up-regulated No. of probes down-regulated
HeLa/Hippi 1037 580 457
Hip1Si/Hip1SiHi 1649 990 659
Common 123 90 33
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Page 7 of 17Figure 3 Enrichment of transcription factor binding sites in the upstream of genes altered in microarray study. A. Genes those were up-
regulated by HIPPI in HeLa cells were analyzed for the presence of transcription factor binding sites in their upstream. The occurrence of a
particular binding motif in the set of up-regulated genes was compared to the background occurrence of that motif and plotted against the TF.
B. Same analysis as in A was done with the genes that were down-regulated by HIPPI in HeLa cells. C. Same analysis as in A was done with the
up-regulated genes those were common in the two sets of microarray. D. Same analysis as in A was done with the down-regulated genes those
were common in the two sets of microarray.
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Page 8 of 17Table 3 Functional classification of the altered genes in microarray study by Gene Ontology
Up-regulated
Molecular function
GO ID GO details Data set
frequency
(%)
Background
frequency
(%)
p value
(unadjusted)
p value
(corrected)
Gene name
GO:0003700 Transcription factor
activity
9.881422925 4.527835754 2.14E-07 3.54E-05 Cbp/p300-interacting transactivator, with Glu/Asp-
rich carboxy-terminal domain, 2, NK2 transcription
factor related, locus 5 (Drosophila), CCAAT/
enhancer binding protein (C/EBP), beta, CREB
binding protein
GO:0003702 RNA polymerase II
transcription factor
activity
2.56916996 0.575030881 7.44E-06 0.000531586 Forkhead box E1 (thyroid transcription factor 2),
Transcription elongation regulator 1
GO:0016564 Transcription repressor
activity
2.766798419 0.72837245 8.03E-06 0.0011916 Peroxisome proliferator-activated receptor delta,
RE1-silencing transcription factor, NADH
dehydrogenase (ubiquinone) 1 alpha subcomplex,
9, 39 kDa
GO:0003682 Chromatin binding 2.56916996 0.758188866 2.16E-05 0.004496337 NK2 transcription factor related, locus 5
(Drosophila), CREB binding protein, RE1-silencing
transcription factor
GO:0003713 Transcription co-
activator activity
2.56916996 0.796524258 3.49E-05 0.006663331 Transcription elongation regulator 1, junction
mediating and regulatory protein, p53 cofactor,
CREB binding protein
GO:0043565 Sequence-specific DNA
binding
5.335968379 2.602547174 3.57E-05 0.01057545 v-rel reticuloendotheliosis viral oncogene homolog
A (avian), CCAAT/enhancer binding protein (C/
EBP), beta, NK2 transcription factor related, locus 5
(Drosophila)
Biological process
GO:0000122 Negative regulation of
transcription from RNA
polymerase II promoter
3.29218107 1.086169442 9.09E-05 0.01248966 SIN3 homolog B, transcription regulator (yeast),
RE1-silencing transcription factor
GO:0006355 Regulation of
transcription, DNA-
dependent
10.08230453 5.865314989 0.000119 0.01575762 Y box binding protein 1, POU class 2 homeobox 2,
NK2 transcription factor related, locus 5
(Drosophila), CCAAT/enhancer binding protein (C/
EBP), beta
GO:0045893 Positive regulation of
transcription, DNA-
dependent
1.851851852 0.442986753 0.000161 0.02283294 Cbp/p300-interacting transactivator, with Glu/Asp-
rich carboxy-terminal domain, 2, Dual-specificity
tyrosine-(Y)-phosphorylation regulated kinase 1B
GO:0045944 Positive regulation of
transcription from RNA
polymerase II promoter
3.703703704 1.478042339 0.000366 0.02283294 Zinc finger and BTB domain containing 38,
CCAAT/enhancer binding protein (C/EBP), beta,
CREB binding protein, Tumor necrosis factor
receptor superfamily, member 1A
GO:0006412 Translation 3.909465021 1.682497764 0.000502 0.03143108 Eukaryotic translation initiation factor 1B,
Eukaryotic translation initiation factor 6
Down-regulated
Molecular functions
GO:0004888 Transmembrane
receptor activity
3.140096618 0.694296546 6.83E-06 0.00066934 G protein-coupled receptor 123, Toll-like receptor
6
GO:0016564 Transcription repressor
activity
2.415458937 0.72837245 4.91E-05 0.02326809 MYB binding protein (P160) 1a, Runt-related
transcription factor 1; translocated to, 1 (cyclin D-
related)
GO:0003714 Transcription co-
repressor activity
1.93236715 0.621885249 0.000116133 0.0479129 Nuclear receptor interacting protein 1, Histone
deacetylase 9
Biological process
GO:0007165 signal transduction 18.29896907 8.71065298 1.50E-09 1.06E-06 Ataxia telangiectasia mutated, Somatostatin
receptor 2, Protein kinase, cAMP-dependent,
regulatory, type II, alpha, Nuclear factor of kappa
light polypeptide gene enhancer in B-cells
inhibitor, beta
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Page 9 of 17genome wide analysis of HBS containing genes in the
first section. Our experimental data, therefore, con-
firmed our predictions.
Since nuclear localization of HIPPI is HIP1 mediated
[9], we next carried out microarray experiment with
HIP1 knocked down HeLa cells (designated as Hip1Si).
Empty GFP vector transfected Hip1Si cells (designated
as Hip1Si-Gfp) were used as controls while Hip1Si cells
transfected with GFP-Hippi construct (designated as
Hip1SiHippi) were used as test. Here, we observed
alteration of 1652 genes of which 990 were up regulated
a n d6 6 2w e r ed o w nr e g u l a t e d( p<0 . 0 5 ,T a b l e2 ) .T h e
level of alteration of the genes in the two sets of micro-
array (HeLa-Gfp/HeLa-Hippi and Hip1Si-Gfp/Hip1Si-
Hippi) was compared. It was expected that the genes
that were regulated by HIPPI would show a diminished
level of alteration in the second case as HIP1 knock
down results in cytoplasmic accumulation of HIPPI [9].
We arbitrarily chose 10% as the cut off values for the
ratios of expression of genes altered by HIPPI in the
presence or reduced expression of HIP1. Such compari-
sons revealed that 90 genes up-regulated by HIPPI in
HeLa cells were decreased in cells where HIP1 was
knocked down. Similarly 33 genes that were decreased
by exogenous expression of HIPPI in HeLa cells with
endogenous HIP1 were increased in HIP1 knocked
down cells. We assigned these 123 genes as the potential
targets of HIPPI-HIP1 mediated transcriptional regula-
tion and termed them as ‘common set’.T h el i s t so f
these genes are shown in the Additional file 3.
The common set of genes was analyzed for the
enrichment of transcription factor binding sites. Binding
motifs of ZID (p = 0.02), ELK1 (p = 0.003), XFD1 (p =
0.02), NFKappaB p50 (p = 0.04), AP2 (p = 0.0009)
CREB (p = 0.01), GC (p = 0.04), Sp1 (p = 0.02) and
AREB6 (p = 0.007, Figure 3c) were enriched in the
upstream of up-regulated genes while down-regulated
genes contained binding sites for EGR3 (p = 0.02),
EGR2 (p = 0.03), CREB (p = 0.03), EVI1/RunX1, (p =
0.02), SREBP1 (p = 0.03), GATA1 (p = 0.02), FOXJ2 (p
= 0.04) and PAX4 (p = 0.003, Figure 3d). Here again
HBS was not enriched. The reason for this could be the
fact that HIPPI is a non conventional transcription fac-
tor and was also found to regulate several transcription
factors like CREB binding protein (CBP), neuron restric-
tive silencing factor (NRSF) etc. Therefore it is expected
that many genes altered in presence of HIPPI could be
due to its secondary effect mediated through the regula-
tion of some of the other crucial transcription factors.
Validation of subset of genes altered in microarray study
A set of genes altered in microarray experiments were
validated using a second method like semi quantitative
RT-PCR. From the list of altered genes in the two sets
o fm i c r o a r r a yw er a n d o m l yc h o s e1 0g e n e sa n dm e a -
sured their level of expression in empty GFP vector
transfected HeLa cells (designated as ‘HeLa’), GFP-Hippi
transfected HeLa cells (designated as ‘Hippi’), empty
GFP vector transfected HIP1 knocked down HeLa cells
(designated as ‘Hip1Si’) and GFP-Hippi transfected HIP1
knocked down HeLa cells (designated as ‘Hip1SiHi’).
Among the 10 genes, expression pattern of 6 genes were
consistent with that of microarray data (Figure 4). Exo-
genous expression of HIPPI in HeLa cells up-regulated
the genes viz. Guanine nucleotide binding protein,
gamma 10 (GNG10), CREB binding protein (CBP),
CCAAT/enhancer binding protein, beta (C/EBPb)a n d
Calcium channel, voltage-dependent, gamma subunit 1
(CACNG1) while CREB3 like 2 (CREB3L2)a n dv e s i c l e
transport through interaction with t-SNAREs homolog
1A (yeast), (VTI1A) were down-regulated. However,
exogenous expression of HIPPI in Hip1Si cells failed to
alter the expression level of these genes indicating that
both HIP1 and HIPPI were required for the transcrip-
tional regulation of these genes. NKX2-5 was initially
found to be up regulated in microarray study. But, semi
quantitative RT-PCR showed that it was actually down-
regulated by HIPPI (Figure 4). Three other genes chosen
(viz. TCERG1, RAX and RelA) were unaltered in pre-
sence of HIPPI (data not shown).
These genes along with some others were also tested
for their expression in presence of HIPPI in a second
cell line like human neuroblastoma cells SHSY5Y. A
comprehensive list summarizing all the single gene
expression data is given in Additional file 7.
Interaction of HIPPI with P53 in the nuclear compartment
of cell and its effect on Caspase1 expression
In the earlier section, using MST we have predicted that
b i n d i n gs i t eo fP 5 3( h a l fs i t e )w a se n r i c h e dn e a rt h e
HBS for the genes containing HBS within their 2 Kb
upstream. To check whether these two proteins could
Table 3 Functional classification of the altered genes in microarray study by Gene Ontology (Continued)
GO:0007268 synaptic transmission 2.835051546 0.694296546 4.92E-07 0.005691273 Neurexin 2, Potassium channel, subfamily K,
member 3, Somatostatin
GO:0000122 negative regulation of
transcription from RNA
polymerase II promoter
3.350515464 1.086169442 2.23E-06 0.01540901 Nuclear receptor interacting protein 1, SP100
nuclear antigen, POU class 3 homeobox 3
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pitation assay. Whole cell extract of Neuro2A cells (that
express both P53 and HIPPI endogenously) showed
positive co-immunoprecipitation of HIPPI with P53
(Figure 5a). To specifically locate the compartment
where the complex was formed, we fractionated Neu-
ro2A cells into cytoplasm and nucleus and observed
that HIPPI co-immunoprecipitated with P53 only in the
nuclear compartment (Figure 5b). To validate it further,
we took HIP1 knocked down Neuro2A cells
(N2AHip1Si) and studied the interaction of HIPPI with
P53. Knock down of HIP1 has been confirmed by wes-
tern blot analysis (Additional file 8). As HIP1 is the
nuclear transporter of HIPPI, knock down of HIP1
restricts HIPPI in the cytoplasm and consequently no
interaction between HIPPI and P53 was observed either
in whole cell extract or in the nuclear compartment of
N2AHip1Si cells (Figure 5c).
The interaction of HIPPI and P53 in the nuclear com-
partment of cell might have important role in HIPPI
mediated transcription regulation. From our microarray
data we have seen that P53 binding site was enriched in
the upstream of up-regulated genes. To elucidate the
functional relevance of this interaction we determined
the level of Caspase1 expression in presence and
absence of these two transcription factors. Human Cas-
pase1 promoter contains a consensus P53 binding site
at the position -117 to -98 from TSS [17]. It also con-
tains a HIPPI binding site at the position -119 to -111
from TSS [6]. Thus to see the combinatorial effect of
HIPPI and P53 on Caspase1 gene expression we trans-
fected GFP-Hippi exogenously in p53 knocked down
HeLa cells (Figure 5d and 5e designated as ‘p53SiHi’).
Knock down of p53 in HeLa cell was confirmed by wes-
tern blot analysis [18]. These cells showed reduced
expression of Caspase1 as compared to HeLa cells trans-
fected with HIPPI (designated as ‘Hippi’, n = 3 p = 0.02)
or P53 alone (designated as ‘p53’, p = 0.03). Co-transfec-
tion of HIPPI and P53 in HeLa cells (designated as ‘p53
+Hippi’) resulted in even higher level of Caspase1
expression compared to the single transfected cells (p =
0.04). Thus in absence of P53, HIPPI alone could not
increase Caspase1 gene expression; rather, the interac-
tion with P53 appeared to be very important for HIPPI
mediated up-regulation of the gene.
HIPPI binding sites at the deregulated genes in the
caudate of HD patients: possible role of HIPPI in HD
The involvement of HIPPI in HD pathogenesis is not
well established but its ability to induce apoptosis
through recruitment and activation of Caspase8 [1] and
increased expression of Caspase1 [2,5-7,9] indicate that
it may have some role in the disease. To elucidate it
further, we first analyzed the distribution of HBS along
the 10 Kb upstream promoters of the genes that were
differentially expressed in a microarray experiment car-
ried out with HD patients [10] (see materials and meth-
ods for details). The distribution was similar to that
Figure 4 Relative expression level of some of the altered genes in microarray study determined by RT-PCR. Expression of beta actin was
taken as control. Error bar represents standard deviation (n = 3). For each gene, expression level in ‘Hippi’ was compared with expression level in
‘HeLa’ and that in ‘Hip1SiHi’ with ‘Hippi’. Significance levels of various pairs are indicated in the figure.
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1). Of the differentially regulated genes that do harbor
HBS in their upstream, the majority of the sites in these
genes were located within 2 Kb of TSS and the fre-
quency of HBS occurrence reduced rapidly with increas-
ing distance from TSS. Next we attempted to see
whether HBS was significantly enriched in the upstream
promoter of these genes. It was observed that HBS was
significantly enriched only in the promoters (10 Kb) of
down-regulated genes (p = 0.002, Additional file 9) but
not in the up-regulated genes (p = 0.866). The altered
genes were further analyzed to see whether any other
transcription factor binding sites, particularly those TFs
that are already known to be involved in HD, were
enriched in their upstream promoters [19-24]. Tran-
scription factors like P300, Sterol response element
binding protein 1 (SREBP1), Sp1 were found to be sig-
nificantly enriched in both up and down regulated genes
but NFKappaB binding sites were enriched in up-regu-
lated genes only while CREB and TATA box binding
protein sites were enriched in down-regulated genes
only (Figure 6b and 6c). This, in fact, correlated with
t h ep r e v i o u sd a t at h a tC R E(cAMP response element)
mediated transcription is down-regulated in HD [19].
Next we functionally classified the altered genes using
GO. Among the various molecular functions and biolo-
gical processes enriched for the up-regulated genes in
HD, we found that molecular function like transcription
factor activity (GO:0003700), chromatin binding
(GO:0003682), transcription co-activator activity
(GO:0003713), sequence-specific DNA binding
(GO:0043565), and biological processes like regulation
of transcription (GO:0045449) were common to that
obtained with genes up-regulated by HIPPI in the
microarray study (Additional file 10). For genes down-
regulated in HD, transcription co-repressor activity
Figure 5 HIPPI interacts with P53 in the nucleus and alters the expression of Procaspase1 in cell. A. Co-immunoprecipitation of HIPPI
with P53 from whole cell extract of Neuro2A cells. IP was carried out with anti P53 antibody and western blot was done with anti HIPPI
antibody (Upper panel). The same blot was stripped and reprobed with anti P53 antibody as IP control (lower panel). Lane ‘In’: input of
immunoprecipitation, ‘+Ab’: cell extract treated with anti P53 antibody, ‘-Ab’: cell extract treated with IgG only. B. Co-immunoprecipitation of
HIPPI with P53 from cytoplasm and nuclear compartment of Neuro2A cells. Cytoplasmic (’CE’) and nuclear (’NE’) fractions were separately
immunoprecipitated with anti P53 antibody and detected with anti HIPPI antibody (Upper panel). The lane markings carry their usual meanings
as described in A. C. Interaction of HIPPI with P53 in cytoplasm and nuclear compartment of N2AHip1Si cells. D. Western blot analysis for the
detection of Procaspase1 expression in parental HeLa cells (’HeLa’), HeLa cells transfected with GFP-Hippi (’Hippi’), p53 knocked down HeLa cells
exogenously transfected with GFP-Hippi (’P53SiHi’), HeLa cells transfected with full length p53 (’P53’) and HeLa cells co-transfected with full
length p53 and GFP-Hippi (’P53+Hippi’). Beta actin was used as loading control. E. Bar diagram represents mean (n = 3) relative expression of
Procaspase1 in different cells described in D above. IOD value of the Procaspase1 specific band was normalized with that of beta actin.
Normalized IOD of ‘HeLa’ was considered to be 1.
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Page 12 of 17(GO:0003714) and synaptic transmission (GO:0007268)
were within enriched category similar to that observed
with genes down-regulated by HIPPI. Thus, the signifi-
cant occurrence of HBS in the upstream of differentially
expressed genes in HD and also the involvement of
these genes in some of the functional categories that
were perturbed by HIPPI in cell suggests that HIPPI
may indeed play transcription regulatory role in the dis-
ease pathogenesis.
From the genes that were altered in HD microarray
discussed above, we chose 4 genes viz. Chemokine (C-C
motif) ligand 5 [CCL5, ENSG00000161570], Inhibitor of
DNA binding 1 [ID1, ENSG00000125968], NADH dehy-
drogenase (ubiquinone) 1 alpha subcomplex, 10, 42 kDa
[NDUFA10, ENSG00000130414] and Inositol 1,4,5-tri-
phosphate receptor, type 1 [ITPR1, ENSG00000150995]
which contained HBS in their upstream (Additional file
6). CCL5 and ID1 were up-regulated while NDUFA10
and ITPR1 were down-regulated in HD. We measured
the expression level of these genes in presence of HIPPI.
Both CCL5 and ID1 expressions were increased and
ITPR1 expression was decreased in presence of HIPPI in
HeLa cells (Figure 7) but remained unaltered in HIP1
knocked down HeLa cells. NDUFA10 expression was
not detected in HeLa cells. CREB binding protein (CBP,
ENSG00000005339) and RE1 Silencing transcription fac-
tor (REST, ENSG00000084093) were also found to be
Figure 6 Distribution of HBS and enrichment of transcription
factor binding sites in the upstream of genes altered in HD.A .
HBS distribution along the 10 Kb upstream regions of the genes
altered in microarray study carried out with HD patients. Distance
was calculated taking the transcription start site (TSS) as ‘0’.
Frequency of occurrence of HBS per kb distance was plotted
against the distance from TSS as described in legend of Figure 1. B.
Enrichment of transcription factor binding sites in the 10 Kb
upstream of genes up-regulated in HD microarray. As described in
Figure 3A, the occurrence of a particular binding motif in the set of
up-regulated genes was compared to the background occurrence
of that motif and plotted against the TF. The p value in the figure
represents the significance level of enrichment for the transcription
factor. C. Enrichment of transcription factor binding sites in the 10
Figure 7 Relative expression level of some of the genes altered
in HD microarray study in presence of HIPPI. Expression of beta
actin was taken as control. Error bar represents standard deviation
(n = 3). For each gene, expression level in ‘Hippi’ was compared
with expression level in ‘HeLa’ and that in ‘Hip1SiHi’ with ‘Hippi’.
Significance levels of various pairs are indicated in the figure.
Kb upstream of genes down-regulated in HD microarray as
described above.
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Page 13 of 17up-regulated in HD (Additional file 7). The alteration of
these two genes in presence of HIPPI has already been
demonstrated by microarray.
Discussion
To investigate the role of HIPPI as a novel transcrip-
tion regulator, we first took bioinformatic approaches
to predict the targets of HIPPI and then tried to
experimentally validate the predictions. Generally, tran-
scription factor binding sites are enriched near the TSS
and the frequency of occurrence of TFBS decreases as
we move further upstream. The predominant occur-
rence of 9 bp consensus HIPPI binding site within 2
Kb upstream sequences of genes was similar to that of
known transcription factor CREB (Figure 1). This indi-
cates that HBS might be functionally active and regu-
late the expression of genes harboring HBS. Next, this
set of predicted HIPPI targets were classified function-
ally using Gene Ontology to understand which biologi-
cal processes or functions could be regulated by HIPPI
in cells. The genes showed significant enrichment for
functional categories related to transcriptional regula-
tion, chromatin binding, signal transduction, receptor
activity and induction of apoptosis (Table 1 and Addi-
tional file 2). It should be mentioned that HIPPI’sr o l e
in apoptosis induction and transcription regulation has
already been reported [1,2,5-7,9]. These functional
categories were also found to be significantly over-
represented when we analyzed our microarray data.
Exogenous expression of HIPPI in HeLa cells resulted
in alteration of ~ 1000 genes of which 580 genes were
up-regulated and 457 genes were down-regulated
(Table 2). Up-regulated genes were mainly enriched in
the functional categories like transcription factor activ-
ity, transcription co-activator activity, chromatin bind-
ing, sequence specific DNA binding, positive regulation
of transcription etc. (Table 3) while down-regulated
genes were enriched in transcription repressor activity,
transcription co-repressor activity, negative regulation
of transcription, synaptic transmission etc. (Table 3).
This suggests that HIPPI could participate in cellular
transcription regulation machinery. To elucidate this
property further, we carried out another set of micro-
array experiment where we blocked nuclear transloca-
tion of HIPPI by knocking down its transporter HIP1
[9]. We then compared the genes altered in the two
sets of microarray. It was expected that genes that
were transcriptional targets of HIPPI would show a
reduced level of alteration in HIP1 knocked down
cells. Results showed that 90 genes that were up-regu-
lated by HIPPI in HeLa cells (having endogenous
H I P 1 )w e r eu p - r e g u l a t e dt oal e s s e re x t e n ti nHIP1
knocked down cells (Table 2 and Additional file 3).
Similar was the case for 33 down-regulated genes. This
subset of altered genes was thus under control of
HIPPI-HIP1 mediated transcription regulation.
While analyzing our microarray data we found that
multiple testing corrections yielded no statistically sig-
nificant probes in the array. We, therefore, took the sin-
gle gene validation approach. From our microarray data
we chose 21 genes (unadjusted p value significant) and
measured their expression in presence of HIPPI using a
second method like semi quantitative RT-PCR or Real
time PCR in HeLa (Figure 4) as well as in a second cell
line (SHSY5Y, Additional file 7). Fifteen among the 21
genes (71%) showed similar trend as observed in micro-
array while one (NKX2-5) showed reverse trend. Five
genes remained unaltered. Among these 16 validated
genes, REST expression was found to be regulated by
HIPPI in both neuronal and non-neuronal cells through
interaction of HIPPI with REST promoter [25]. Further
analysis of these 16 genes using GO revealed that they
were enriched in functions like transcription factor
activity, transcription co-activator activity, chromatin
binding, sequence specific DNA binding and processes
like regulation of transcription DNA dependent, positive
and negative regulation of transcription from RNA pol
II promoter etc. (Additional file 7) similar to those
obtained with genome wide analysis (Table 1) and
microarray analysis (Table 3). Thus, even though multi-
ple testing of array data indicated lack of statistical sig-
nificance for the altered probes, our single gene
validation experiments suggest that HIPPI indeed inter-
feres with these processes in cell.
Gene expression regulation is a complex phenomenon
involving participation of several transcription factors in
a co-operative manner [16]. To find out the transcrip-
tion factor partners of HIPPI we carried out enrichment
analysis for TF binding motifs within a fixed 100 bp dis-
tance from HBS (Figure 2a). Several transcription factor
binding motifs, including NFAT, C/EBP beta, P53,
TATA box binding protein, CREBP1 were over-repre-
sented in the 100 bp vicinity of HBS (Figure 2b). Pre-
sence of TBP, CREBP1 binding sites suggest that HIPPI
may take part in basal transcription regulation machin-
ery in cell. Among these TFs, C/EBP beta was found to
be up-regulated by HIPPI (Figure 4 and Additional file
3). Binding motifs for GATA1, FOXJ2 and EVI1 have
been enriched in the upstream of genes down-regulated
by HIPPI (Figure 3c and 3d). Thus, interaction of HIPPI
with these TFs may result in transcriptional repression.
It was somewhat surprising that HBS was not enriched
in the upstream of altered genes. One possible explana-
tion for this could be the fact that HIPPI is not a con-
ventional transcription factor (without DNA binding
and transactivation domain). It is, therefore, possible
that over-expression of HIPPI in cell increased its inter-
action with other cellular proteins rather than with
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stituted only a small fraction among the perturbed
genes [26]. Rest of the altered genes constituted the sec-
ondary target set that were differentially expressed in
response to the primary set or the changes in cellular
physiology brought about by the primary set. For exam-
ple, GATA3 and EVI1 were down-regulated by HIPPI in
microarray study (Additional file 3). Binding sites for
GATA3 and EVI1 were enriched in the upstream of
down-regulated genes (Figure 3b). Thus a subset of
genes down-regulated by HIPPI was effect of GATA3 or
EVI1 down-regulation. This was also true for REST.
Transcription repressor REST was up-regulated by
HIPPI and consequently REST binding site was enriched
in the upstream of down-regulated genes (Additional file
4). Similarly increased expression of CBP by HIPPI may
result in increased histone acetylation leading to up-reg-
ulation of certain genes. It seems therefore important to
analyze the primary set (those harboring HBS) sepa-
rately from the bulk to understand direct transcription
regulatory role of HIPPI. The similarities in GO classes
between the primary set (Additional file 6) and those
predicted from genome wide analysis (Additional file 2)
indicates that these cellular processes were indeed per-
turbed by HIPPI.
HIPPI was found to interact with P53 in the protein
level. This interaction took place in the nucleus (Figure
5b) and was dependent on the presence of HIP1, the
nuclear transporter of HIPPI as HIPPI did not co-
immunoprecipitate with P53 in the nuclear compart-
ment of HIP1 knocked down cells (Figure 5c). This
interaction was found to be necessary for HIPPI
mediated up-regulation of Caspase1 gene expression.
Human Caspase1 gene contains overlapping P53 bind-
ing site (position -117 to -98, [17]) and HIPPI binding
site (position -119 to -111, [6]) in the promoter. It was
observed that HIPPI could not induce Caspase1 expres-
sion in p53 knocked down HeLa cells (Figure 5d and 5e,
comparing ‘Hippi’ with ‘p53SiHi’). When both HIPPI
and P53 were co-expressed, the expression of Caspase1
was strongly enhanced compared to the corresponding
single transfected cells (Figure 5d and 5e, comparing
‘Hippi’ and ‘p53’ with ‘p53+Hippi’) indicating that both
the transcription factors co-operated to regulate this
gene expression. Such interaction may also play role in
HD pathogenesis. It is observed that P53 protein level is
increased in HD cell model [18]. Also HIPPI-HIP1
interaction is more in the diseased condition [1] which
in turn may increase nuclear pool of HIPPI in cell.
Therefore, the combinatorial effect of these two regula-
tors will be more in the diseased condition.
Deregulation of transcription and induction of neuro-
nal apoptosis are two of the major contributors to the
pathogenesis of HD. Gervais and co-workers identified a
novel non receptor mediated apoptotic cascade invol-
ving HIPPI and HIP1 that could operate in HD [1].
Work of Majumder et al., and Banerjee et al., imparted
a transcription regulatory activity of HIPPI [2,5,6,9]. We
therefore, tried to analyze the role of HIPPI in the dis-
ease pathogenesis. Microarray data obtained from HD
patients [10] was analyzed for the enrichment of HBS in
the upstream of altered genes and we found that HIPPI
binding sites were enriched in the set of genes that were
down-regulated in HD (Figure 6c). Additionally, the
functional categories in which the altered genes in HD
belong, bared similarity with the functions played by the
HIPPI regulated genes. This includes transcription factor
activity (GO:0003700), chromatin binding (GO:0003682),
transcription co-activator activity (GO:0003713) for the
up-regulated genes and transcription co-repressor activ-
ity (GO:0003714) and synaptic transmission
(GO:0007268) for the down-regulated genes. We have
shown that transcription co-activator CBP was up-regu-
lated by HIPPI which can lead to transcriptional activa-
tion of a vast array of genes. Similarly, expression of
ID1, an inhibitor that prevents DNA binding of basic
helix-loop-helix transcription factors was up-regulated
in presence of HIPPI which may cause repression of
genes. Recently we have reported that HIPPI mediated
transcriptional induction of REST plays an important
role in repressing essential neuronal genes such as
BDNF in HD cell model [25]. Thus HIPPI mediated
transcriptional regulation may indeed contribute to the
transcription deregulation observed in HD.
In summary, the manuscript addresses the potential
transcription regulatory role played by HIPPI in cell.
Using bioinformatic approach we identified a group of
HIPPI regulated genes and their possible functions and
subsequently validated them with microarray experi-
ments. Although the lack of multiple testing corrections
in array data is a limitation of this study, the similarities
between functional classes of predicted and experimen-
tally altered genes indicate perturbation of these func-
tions by HIPPI in cells. We also predicted possible co-
operativity of HIPPI with other transcription factors in
the regulation of gene expression and have shown the
synergistic role of HIPPI and P53 in regulation of Cas-
pase1 expression. Finally, the involvement of HIPPI
mediated transcription regulation is assessed in the con-
text of Huntington’s disease pathogenesis.
Conclusion
In conclusion, the work presented here identifies new
transcriptional targets of HIPPI. It also reveals new
interaction between HIPPI and P53 and the effect of
such interaction in cell. Finally the work predicts the
involvement of HIPPI in HD pathogenesis. It would be
of immense interest to investigate in detail, the
Datta et al. BMC Genomics 2011, 12:463
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Additional file 1: Genome wide occurrence of HBS within 2 Kb
upstream sequences. The file contains list of the genes that harbor HBS
within their 2 Kb upstream promoter including the exact position and
sequence of the motif matched.
Additional file 2: GO classification of genes having HBS within 2 Kb
upstream. The file contains significant molecular functions and
biological processes in which the genes harboring HBS within 2 Kb
upstream are involved.
Additional file 3: List of genes altered in microarray study. The file
contains details of the genes altered in HeLa-Gfp/HeLa-Hippi and Hip1Si-
Gfp/Hip1SiHippi microarray study and also the list of genes in the
common set including their fold change
Additional file 4: Transcription factor binding site analysis by
Genecodis in the upstream of genes altered by HIPPI in microarray.
The file contains lists of transcription factors that are significantly
enriched in the upstream of genes altered by HIPPI in microarray.
Additional file 5: GO classification of genes altered in HeLa-Gfp/
HeLa Hippi microarray. The file contains lists of molecular functions
and biological processes significantly enriched for the genes altered by
HIPPI in microarray study.
Additional file 6: GO classification of genes altered in HeLa-Gfp/
HeLa Hippi microarray which contain HBS within 10 Kb upstream.
The file contains lists of molecular functions and biological processes
significantly enriched for those genes that contain HBS within 10 Kb
upstream and are altered by HIPPI in microarray study.
Additional file 7: Single gene expression analysis for genes altered
in presence of HIPPI. The file contains list of the genes whose
expression was measured in presence of HIPPI in various cell lines using
various methods. It also contains significantly enriched GO terms for
these altered genes.
Additional file 8: Knock down of HIP1 in Neuro2A cells. A. Western
blot analysis for the detection of HIP1 (upper panel) in Neuro2A cells
(designated as N2A) and N2A cells stably transfected with Hip1Si
construct to knock down HIP1 (designated as N2AHip1Si). In the lower
panel, the 42 KDa band represents beta actin as loading control. B: The
bar diagram represents mean integrated optical densities of bands
corresponding to HIP1 and normalized with that of the loading control
beta actin. Level of significance (p values) is shown in the figure.
Additional file 9: List of genes harboring HBS within 10 Kb
upstream among the genes altered in HD microarray. The file
contains list of the genes that are altered in HD microarray and also
harbor HBS within their 10 Kb upstream promoter including the exact
position and sequence of the motif matched.
Additional file 10: GO classification of genes altered in HD
microarray study. The file contains lists of molecular functions and
biological Processes significantly enriched for the genes altered in HD
microarray study.
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